Ticker Hub
GANX — AI Analysis & Sentiment
3 recent AI-generated analyses for GANX. Sentiment and confidence insights updated continuously.
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
Gain Therapeutics reported significant cash balance improvement and positive clinical updates for its lead Parkinson's drug candidate, GT-02287, an...
Mar 26, 2026Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
Gain Therapeutics announced encouraging additional clinical data for its lead Parkinson's drug, GT-02287, and advanced a new preclinical candidate....
Mar 18, 2026Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
Gain Therapeutics shared encouraging early clinical data and maintained its regulatory timeline for GT-02287, de-risking its lead asset. This creat...
Mar 12, 2026